Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance

被引:259
作者
Boess, FG
Hendrix, M [1 ]
van der Staay, FJ
Erb, C
Schreiber, R
van Staveren, W
de Vente, J
Prickaerts, J
Blokland, A
Koenig, G
机构
[1] Bayer HealthCare, Forschungszentrum Aprather Weg, D-42096 Wuppertal, Germany
[2] Bayer HealthCare, Pharma Res CNS, D-42096 Wuppertal, Germany
[3] Univ Maastricht, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands
[4] Univ Maastricht, Dept Neurocognit, NL-6200 MD Maastricht, Netherlands
关键词
phosphodiesterase; 2; PDE2; cGMP; long-term potentiation; LTP; memory; learning;
D O I
10.1016/j.neuropharm.2004.07.040
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
An essential element of the signalling cascade leading to synaptic plasticity is the intracellular second messenger molecule guanosine 3',5'-cyclic monophosphate (cGMP). Using the novel, potent, and selective inhibitor Bay 60-7550, we show that the enzyme 3',5'-cyclic nucleotide phosphodiesterase type 2 (PDE2) is responsible for the degradation of newly synthesized cGMP in cultured neurons and hippocampal slices. Inhibition of PDE2 enhanced long-term potentiation of synaptic transmission without altering basal synaptic transmission. Inhibition of PDE2 also improved the performance of rats in social and object recognition memory tasks, and reversed MK801-induced deficits in spontaneous alternation in mice in a T-maze. Our data provide strong evidence that inhibition of PDE2 can improve memory functions by enhancing neuronal plasticity. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1081 / 1092
页数:12
相关论文
共 74 条
[31]   CLONING AND FUNCTIONAL-CHARACTERIZATION OF A HUMAN A1 ADENOSINE RECEPTOR [J].
LIBERT, F ;
VANSANDE, J ;
LEFORT, A ;
CZERNILOFSKY, A ;
DUMONT, JE ;
VASSART, G ;
ENSINGER, HA ;
MENDLA, KD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 187 (02) :919-926
[32]  
LONDON ED, 1979, MOL PHARMACOL, V15, P492
[33]   Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase [J].
Loughney, K ;
Hill, TR ;
Florio, VA ;
Uher, L ;
Rosman, GJ ;
Wolda, SL ;
Jones, BA ;
Howard, ML ;
McAllister-Lucas, LM ;
Sonnenburg, WK ;
Francis, SH ;
Corbin, JD ;
Beavo, JA ;
Ferguson, K .
GENE, 1998, 216 (01) :139-147
[34]  
Lu YF, 1999, J NEUROSCI, V19, P10250
[35]   Long-term potentiation and memory [J].
Lynch, MA .
PHYSIOLOGICAL REVIEWS, 2004, 84 (01) :87-136
[36]   RECEPTORS FOR 5-HYDROXYTRYPTAMINE - CURRENT PERSPECTIVES ON CLASSIFICATION AND NOMENCLATURE [J].
MARTIN, GR ;
HUMPHREY, PPA .
NEUROPHARMACOLOGY, 1994, 33 (3-4) :261-273
[37]   [H-3]MUSCIMOL BINDING-SITE ON PURIFIED BENZODIAZEPINE RECEPTOR [J].
MARTINI, C ;
RIGACCI, T ;
LUCACCHINI, A .
JOURNAL OF NEUROCHEMISTRY, 1983, 41 (04) :1183-1185
[38]  
MARTINS TJ, 1982, J BIOL CHEM, V257, P1973
[39]  
MATSUOKA I, 1992, J NEUROSCI, V12, P3350
[40]  
MERY PF, 1994, FASEB J, V8, pA82